PRONTOX – proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial
Primary radiochemotherapy with photons is the standard treatment for locally advanced-stage non-small cell lung cancer (NSCLC) patients. Acute radiation-induced side effects such as oesophagitis and radiation ...
Source: Trials - Category: Journals (General) Authors: Sebastian Zschaeck, Monique Simon, Steffen L öck, Esther G. C. Troost, Kristin Stützer, Patrick Wohlfahrt, Steffen Appold, Sebastian Makocki, Rebecca Bütof, Christian Richter, Michael Baumann and Mechthild Krause Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | General Medicine | Lung Cancer | Non-Small Cell Lung Cancer | Proton Therapy | Study | Toxicology